Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $703,221 - $874,233
2,900 Added 362.5%
3,700 $909,000
Q2 2022

Aug 12, 2022

SELL
$224.73 - $338.64 $1.3 Million - $1.96 Million
-5,800 Reduced 87.88%
800 $198,000
Q1 2022

May 13, 2022

BUY
$277.25 - $366.29 $554,500 - $732,580
2,000 Added 43.48%
6,600 $2.19 Million
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $4.6 Million - $5.68 Million
-15,300 Reduced 76.88%
4,600 $1.65 Million
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $2.02 Million - $2.45 Million
6,500 Added 48.51%
19,900 $6.48 Million
Q2 2021

Aug 13, 2021

BUY
$262.71 - $351.17 $525,420 - $702,340
2,000 Added 17.54%
13,400 $4.18 Million
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $28.7 Million - $35.7 Million
-100,500 Reduced 89.81%
11,400 $3.63 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $1.89 Million - $2.43 Million
-7,500 Reduced 6.28%
111,900 $36.3 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $6.87 Million - $8.53 Million
26,900 Added 29.08%
119,400 $33.1 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $13 Million - $23.6 Million
91,800 Added 13114.29%
92,500 $22.3 Million
Q4 2019

Feb 13, 2020

SELL
$159.31 - $223.54 $127,448 - $178,832
-800 Reduced 53.33%
700 $119,000
Q3 2019

Nov 08, 2019

SELL
$175.89 - $279.23 $1.14 Million - $1.81 Million
-6,500 Reduced 81.25%
1,500 $267,000
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $125,480 - $142,470
-500 Reduced 5.88%
8,000 $2.08 Million
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $1.77 Million - $2.32 Million
-6,400 Reduced 42.95%
8,500 $2.43 Million
Q4 2018

Feb 13, 2019

SELL
$281.08 - $444.25 $7.06 Million - $11.2 Million
-25,100 Reduced 62.75%
14,900 $4.84 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $14.2 Million - $18 Million
40,000 New
40,000 $18 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.